Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesIn situ neoplasmsICD-10-CM d03-melanoma-in-situ
    Ask Trek AI about this page

    ICD-10-CM Code For Melanoma In Situ: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group D03 includes noninvasive malignant melanocytic lesions confined to the epidermis, specifying melanoma in situ by anatomic site such as skin of the trunk, limbs, face, scalp, neck, and other locations. These ICD-10-CM diagnosis codes are used to document clinical encounters for primary in situ melanoma, capture tumor location and extent, and distinguish noninvasive from invasive disease for staging and treatment planning. Accurate coding within the ICD-10-CM D03 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Melanoma In Situ: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM D03: Melanoma In Situ Overview

    The D03 group represents melanoma in situ, a noninvasive malignant melanocytic tumor confined to the epidermis affecting the skin. These diagnoses target dermatologic oncology and specify tumor location without invasion. Accurate coding matters for clinical records and influences reimbursement because it distinguishes in situ from invasive melanoma.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when examination and pathology confirm malignant melanocytic lesion limited to the epidermis without evidence of invasion. Assign the specific site code that corresponds to the documented anatomic location of the melanoma in situ.

    ICD-10-CM Codes

    23 rows

    ICD-10-CM CodeDescription
    D03.0Melanoma in situ of lip
    D03.10Melanoma in situ of unspecified eyelid, including canthus
    D03.111Melanoma in situ of right upper eyelid, including canthus
    D03.112Melanoma in situ of right lower eyelid, including canthus
    D03.121Melanoma in situ of left upper eyelid, including canthus
    D03.122Melanoma in situ of left lower eyelid, including canthus
    D03.20Melanoma in situ of unspecified ear and external auricular canal
    D03.21Melanoma in situ of right ear and external auricular canal
    D03.22Melanoma in situ of left ear and external auricular canal
    D03.30Melanoma in situ of unspecified part of face
    D03.39Melanoma in situ of other parts of face
    D03.4Melanoma in situ of scalp and neck
    D03.51Melanoma in situ of anal skin
    D03.52Melanoma in situ of breast (skin) (soft tissue)
    D03.59Melanoma in situ of other part of trunk
    D03.60Melanoma in situ of unspecified upper limb, including shoulder
    D03.61Melanoma in situ of right upper limb, including shoulder
    D03.62Melanoma in situ of left upper limb, including shoulder
    D03.70Melanoma in situ of unspecified lower limb, including hip
    D03.71Melanoma in situ of right lower limb, including hip

    Showing 1–20 of 23

    DRG Codes

    4 rows

    DRG CodeDescription
    124Other Disorders of the Eye with MCC or Thrombolytic Agent
    125Other Disorders of the Eye without MCC
    595Major Skin Disorders with MCC
    596Major Skin Disorders without MCC

    Typical Clinical Scenarios

    • A middle-aged patient presents to dermatology after noticing a slowly enlarging, irregularly pigmented macule on the left cheek that has not invaded surrounding tissue on dermoscopic exam; a punch biopsy returns histopathology consistent with melanoma confined to the epidermis (in situ) on the face. The visit is for diagnostic confirmation and treatment planning (excision or Mohs) for a noninvasive lesion. Typical codes: D03.11, D03.111, D03.112.
    • An elderly patient with multiple actinic lesions attends a skin-cancer screening clinic where a suspicious flat lesion on the posterior trunk is biopsied and reported as melanoma in situ; the patient has no prior melanoma history and presents for definitive excision and surveillance given high cumulative sun exposure. This represents a new, localized in situ neoplasm discovered on screening rather than an acute symptomatic episode. Typical codes: D03.20, D03.21, D03.22.
    • A young adult previously treated for invasive melanoma returns for routine follow-up and a newly identified lesion on the scalp is biopsied and diagnosed as superficial spreading melanoma in situ; management focuses on local excision and coordination with oncology for surveillance because of the prior melanoma history. This scenario is a comorbidity/recurrence-risk situation where an in situ lesion is documented in a patient with prior melanoma care. Typical codes: D03.30, D03.39.

    Related Codes

    D00-CARCINOMA-IN-SITU-ORAL-ESOPHAGUS-STOMACH

    ICD-10-CM Code For Carcinoma In Situ Of Oral Cavity, Esophagus And Stomach: Group Overview

    D01-CARCINOMA-IN-SITU-DIGESTIVE

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Digestive Organs: Group Overview

    D02-CARCINOMA-IN-SITU-MIDDLE-EAR-RESPIRATORY

    ICD-10-CM Code For Carcinoma In Situ Of Middle Ear And Respiratory System: Group Overview

    D04-CARCINOMA-IN-SITU-OF-SKIN

    ICD-10-CM Code For Carcinoma In Situ Of Skin: Group Overview

    D05-CARCINOMA-IN-SITU-OF-BREAST

    ICD-10-CM Code For Carcinoma In Situ Of Breast: Group Overview

    D06-CARCINOMA-IN-SITU-OF-CERVIX-UTERI

    ICD-10-CM Code For Carcinoma In Situ Of Cervix Uteri: Group Overview

    D07-CARCINOMA-IN-SITU-GENITAL-ORGANS

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Genital Organs: Group Overview

    D09-CARCINOMA-IN-SITU-OTHER-UNSPECIFIED-SITES

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Sites: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.